Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-ART-58436
Regen Ther 2021 Aug 24;18:275-280. doi: 10.1016/j.reth.2021.08.001.
Show Gene links Show Anatomy links

Modeling human congenital disorders with neural crest developmental defects using patient-derived induced pluripotent stem cells.

Okuno H , Okano H .


???displayArticle.abstract???
The neural crest is said to be the fourth germ layer in addition to the ectoderm, mesoderm and endoderm because of its ability to differentiate into a variety of cells that contribute to the various tissues of the vertebrate body. Neural crest cells (NCCs) can be divided into three functional groups: cranial NCCs, cardiac NCCs and trunk NCCs. Defects related to NCCs can contribute to a broad spectrum of syndromes known as neurocristopathies. Studies on the neural crest have been carried out using animal models such as Xenopus, chicks, and mice. However, the precise control of human NCC development has not been elucidated in detail due to species differences. Using induced pluripotent stem cell (iPSC) technology, we developed an in vitro disease model of neurocristopathy by inducing the differentiation of patient-derived iPSCs into NCCs and/or neural crest derivatives. It is now possible to address complicated questions regarding the pathogenetic mechanisms of neurocristopathies by characterizing cellular biological features and transcriptomes and by transplanting patient-derived NCCs in vivo. Here, we provide some examples that elucidate the pathophysiology of neurocristopathies using disease modeling via iPSCs.

???displayArticle.pubmedLink??? 34504908
???displayArticle.link??? Regen Ther


Species referenced: Xenopus laevis
Genes referenced: chd7 ephb1 otx2 pax6 slc12a3 sox1 tbx1

???displayArticle.disOnts??? paraganglioma [+]

???attribute.lit??? ???displayArticles.show???
References [+] :
Acloque, Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. 2009, Pubmed